These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 33991530)
61. Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Zumerle S; Mathieu JR; Delga S; Heinis M; Viatte L; Vaulont S; Peyssonnaux C Blood; 2014 Jun; 123(23):3646-50. PubMed ID: 24646470 [TBL] [Abstract][Full Text] [Related]
62. Disordered hepcidin-ferroportin signaling promotes breast cancer growth. Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806 [TBL] [Abstract][Full Text] [Related]
63. Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload. Camberlein E; Abgueguen E; Fatih N; Canonne-Hergaux F; Leroyer P; Turlin B; Ropert M; Brissot P; Loréal O Biochim Biophys Acta; 2010 Mar; 1802(3):339-46. PubMed ID: 20045050 [TBL] [Abstract][Full Text] [Related]
64. Hepcidin. Ganz T Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588 [TBL] [Abstract][Full Text] [Related]
65. Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2. Rishi G; Secondes ES; Wallace DF; Subramaniam VN Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G171-80. PubMed ID: 26608187 [TBL] [Abstract][Full Text] [Related]
66. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis. Ludwiczek S; Theurl I; Bahram S; Schümann K; Weiss G J Cell Physiol; 2005 Aug; 204(2):489-99. PubMed ID: 15744772 [TBL] [Abstract][Full Text] [Related]
67. Mice with hepcidin-resistant ferroportin accumulate iron in the retina. Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980 [TBL] [Abstract][Full Text] [Related]
68. Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice. Cavey T; Latour C; Island ML; Leroyer P; Guggenbuhl P; Coppin H; Roth MP; Bendavid C; Brissot P; Ropert M; Loréal O FASEB J; 2019 Oct; 33(10):11072-11081. PubMed ID: 31298936 [TBL] [Abstract][Full Text] [Related]
69. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. Babitt JL; Huang FW; Xia Y; Sidis Y; Andrews NC; Lin HY J Clin Invest; 2007 Jul; 117(7):1933-9. PubMed ID: 17607365 [TBL] [Abstract][Full Text] [Related]
70. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Rivera S; Nemeth E; Gabayan V; Lopez MA; Farshidi D; Ganz T Blood; 2005 Sep; 106(6):2196-9. PubMed ID: 15933050 [TBL] [Abstract][Full Text] [Related]
71. The pathophysiology and pharmacology of hepcidin. Ruchala P; Nemeth E Trends Pharmacol Sci; 2014 Mar; 35(3):155-61. PubMed ID: 24552640 [TBL] [Abstract][Full Text] [Related]
72. The role of hepcidin and ferroportin in iron absorption. Oates PS Histol Histopathol; 2007 Jul; 22(7):791-804. PubMed ID: 17455153 [TBL] [Abstract][Full Text] [Related]
73. Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization. Agoro R; Mura C Blood Cells Mol Dis; 2016 Oct; 61():16-25. PubMed ID: 27667162 [TBL] [Abstract][Full Text] [Related]
74. Mechanisms of cardiac iron homeostasis and their importance to heart function. Lakhal-Littleton S Free Radic Biol Med; 2019 Mar; 133():234-237. PubMed ID: 30107217 [TBL] [Abstract][Full Text] [Related]
75. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia. Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596 [TBL] [Abstract][Full Text] [Related]
76. Genetic Iron Overload Hampers Development of Cutaneous Leishmaniasis in Mice. Charlebois E; Li Y; Wagner V; Pantopoulos K; Olivier M Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675185 [TBL] [Abstract][Full Text] [Related]
77. Hepcidin and disorders of iron metabolism. Ganz T; Nemeth E Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198 [TBL] [Abstract][Full Text] [Related]
78. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116 [TBL] [Abstract][Full Text] [Related]
79. New insights into the regulation of iron homeostasis. Deicher R; Hörl WH Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833 [TBL] [Abstract][Full Text] [Related]
80. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload. Duca L; Delbini P; Nava I; Vaja V; Fiorelli G; Cappellini MD Am J Hematol; 2009 Sep; 84(9):592-3. PubMed ID: 19610021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]